A vial and syringe are seen in front of Keytruda logo in this illustration taken March 26, 2025. REUTERS/Dado Ruvic/Illustration Feb 4 (Reuters) - Some cancer therapies may be more effective when ...

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare"), a global leader in providing financing to advance innovation in the life sciences industry, announces that it will hold a conference ...

IntoCell nears Samsung Bioepis deal as phase 1 starts, milestone hopes rise Phase 1 launch of Samsungs first in-house ADC could trigger IntoCell milestone payouts despite ongoing losses ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Health Canada has approved KEYTRUDA SC™ (pembrolizumab injection), a new subcutaneous formulation of ...

Keytruda, a Merck cancer immunotherapy that has become the world’s top-selling medication, is administered as an intravenous infusion over the course of 30 minutes. The pharmaceutical giant now has ...

The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck & Co. Inc.’s MRK Keytruda (pembrolizumab) and ...

MADISON, Wis.--(BUSINESS WIRE)--The National Medical Products Administration (NMPA) has approved the OncoMate ® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro diagnostic ...

A breakthrough personalized mRNA cancer vaccine that trains the immune system to target patients' unique tumor mutations is showing promising results. Five-year trial data show the risk of recurrence ...

By Atharva Singh and Arasu Kannagi Basil Feb 5 (Reuters) - Drug developer Eikon Therapeutics, headed by Merck veteran Roger Perlmutter, was valued at about $860.3 million after its shares opened 5.3% ...

Monoclonal antibodies offer key opportunities in precision immunotherapy for cancer and chronic diseases. Focus areas include targeted novel therapies, stereo-specific antibodies for enhanced efficacy ...

Feb 4 (Reuters) - Some cancer therapies may be more effective when given earlier in the day, aligning treatment with the body's natural rhythms, a Chinese study found, confirming earlier evidence.

How Does Keytruda Work for RCC? Some cancer cells have what are called checkpoint proteins known as PD-L1 on their cell surface. Some immune cells in our bodies called T cells have proteins on their ...